EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against Valeant Pharmaceuticals International, Inc. - VRX

NEW YORK--()--Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of shareholders of Valeant Pharmaceuticals International, Inc. (NYSE:VRX) resulting from allegations that Valeant may have issued materially misleading business information to the investing public.

On October 19, 2015, Southern Investigative Reporting Foundation issued a report on Valeant revealing an undisclosed relationship between Valeant and specialty pharmacy Philidor Rx Services. On this news, shares of Valeant fell $13.73 per share or over 7% to close at $163.83 per share on October 19, 2015. On October 21, 2015, Citron Research issued a report on Valeant asserting, among other things, that Valeant and Philidor have created an entire network of phantom captive pharmacies to create fake sales of drugs or to avoid scrutiny from auditors. On this news, shares of Valeant fell sharply during intraday trading on October 21, 2015, damaging investors.

Rosen Law Firm is preparing a class action lawsuit to recover losses suffered by Valeant investors. If you purchased shares of Valeant on or before October 21, 2015, please visit the firm’s website at http://rosenlegal.com/cases-757.html for more information. You may also contact Phillip Kim, Esq. or Kevin Chan, Esq. of Rosen Law Firm toll free at 866-767-3653 or via email at pkim@rosenlegal.com or kchan@rosenlegal.com.

Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contacts

Laurence Rosen, Esq.
Phillip Kim, Esq.
Kevin Chan, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 34th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
lrosen@rosenlegal.com
pkim@rosenlegal.com
kchan@rosenlegal.com
www.rosenlegal.com

Release Summary

Rosen Law Firm Representing Valeant Pharmaceuticals International, Inc. Shareholders in Securities Class Action - VRX

Contacts

Laurence Rosen, Esq.
Phillip Kim, Esq.
Kevin Chan, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 34th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
lrosen@rosenlegal.com
pkim@rosenlegal.com
kchan@rosenlegal.com
www.rosenlegal.com